Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6293 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

OpenSAFELY team awarded Queen Elizabeth Prize for Higher and Further Education

Oxford’s OpenSAFELY team wins the prestigious Queen Elizabeth Prize for revolutionising secure NHS data research, protecting patient privacy while unlocking life-saving health insights.

Bridging the gap between epilepsy and mental health

A more holistic approach is urgently needed to treat people with epilepsy and co-occurring mental health disorders, according to a new paper.

Unequal access to early pregnancy scans delays detection of serious conditions

Early screening resulted in earlier detection for 40% of anomalies, including heart and limb issues. Researchers from the University of Oxford, together with colleagues from the NHS and other partners, have published the first population-level study linking first-trimester ultrasound practice with early detection rates for serious congenital anomalies.

New analysis highlights urgent need to close global gaps in genomic surveillance of antimicrobial resistance

A major new study led by the University of Oxford and global partners has exposed significant global blind spots in genomic surveillance of antimicrobial resistance (AMR), warning that large parts of the world lack the data needed to track and respond to emerging threats.

Innovative brain health clinic has now assessed 500 patients and improved accuracy of dementia diagnosis

One of the UK’s first Brain Health Clinics is marking two major milestones as it celebrates five years since it launched and more than 500 patients using its services.

Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary

Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.

Study finds no increased safety risk for obese patients undergoing shoulder replacement surgery

Higher BMI is not linked to increased risk of death or other complications following shoulder replacement surgery, according to a new study by Epaminondas Markos Valsamis from NDORMS, University of Oxford.

Women in Clinical Neurosciences (WICN) event reflects on pilot mentorship programme

An exciting research culture event on 17 October 2025 highlighted an ongoing pilot mentorship programme in the department, developed and led by the WICN group.

New study investigates cause of repetitive negative thoughts

Repetitive negative thoughts will be investigated using a range of cutting-edge brain science techniques as part of a new study led by the University of Oxford and funded by Wellcome.

Sir Paul Nurse officially opens the Life and Mind building

The Life and Mind building, a £200 million world-class teaching and research facility, has been officially opened by Sir Paul Nurse, Principal Group Leader, The Francis Crick Institute, President Elect of the Royal Society, and 2001 Nobel Laureate in Physiology or Medicine.

Both total and partial knee replacements deliver lasting benefits at 10 years

New research from a randomised clinical trial provides the strongest long-term evidence yet comparing partial (PKR) and total (TKR) knee replacements for patients with osteoarthritis. Published in The Lancet Rheumatology, the study shows both PKR and TKR being equally effective and offering similar clinical outcomes.

Shared Learning in Cancer Research: Brazilian Health Leaders Visit Oxford

Professor Tim Elliott and colleagues from Oxford Cancer and the Centre for Immuno-Oncology welcomed the Brazilian Minister of Health and senior officials for an official visit organised by the British Embassy in Brazil. The delegation met to exchange insights on cancer research, regulation, and public health, with discussions focusing on prevention, early diagnosis, and innovative treatments such as mRNA vaccines and immunotherapy.

Early Diagnosis Saves Lives: New Study Highlights Critical Window for Postpartum Haemorrhage Care

A new international study co-led by Professor Arri Coomarasamy of the University of Birmingham and the Nuffield Department of Women’s and Reproductive Health, University of Oxford, has shown that diagnosing postpartum haemorrhage (PPH) within the first 90 minutes after childbirth can be crucial in preventing maternal deaths.

Oxford and GSK launch Experimental Medicine Collaboration

GSK invests £10 million over five years to establish the Experimental Medicine Collaboration with the University of Oxford.

Two Oxford academics receive ERC Synergy Grants to tackle major scientific challenges

Two Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants foster collaboration between outstanding researchers, enabling them to combine their expertise, knowledge and resources to push the boundaries of scientific discovery.

World’s first lung cancer prevention vaccine gets £2 million for clinical trial

People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.

Study reveals how drug resistance develops early in targeted AML therapy

A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.

Shaping immunity - the secrets behind the shape of neutrophils

Researchers at the Kennedy Institute have provided the most comprehensive overview to date of how the distinctive segmented nucleus of neutrophils influences their function in health and disease.

Tobacco deaths: the past 75 and the next 75, a guest lecture with Professor Sir Richard Peto

Leading researchers from the Nuffield Department of Primary Care Health Sciences and Nuffield Department of Population Health came together this week for a special event highlighting the enduring impact of research into tobacco addiction and public health.

2025 Teaching Excellence Awards

The Teaching Excellence Awards recognise and reward excellence in teaching, supervision, the organisation and development of teaching, and support for teaching and learning, within a research-intensive environment.

Load More